Decision Making and Symptom Control in End Stage Kidney Disease
|
|
- Marion Terry
- 7 years ago
- Views:
Transcription
1 Decision Making and Symptom Control in End Stage Kidney Disease KCAT Primary Care Workshop This workshop was conceived and developed by the Kidney Check Australia Taskforce with particular thanks to A/Prof Robyn Langham and the St George Hospital (Sydney) Renal Palliative Care Section 1 V0914
2 KCAT supporters The KCAT program is proudly supported by unrestricted educational grants from: KCAT program partners KCAT major sponsor 2
3 Learning outcomes At the end of this presentation participants will be able to: Describe supportive care as a treatment option for end stage kidney disease (ES Recognise and manage common symptoms and complications in ESKD Outline the components of terminal phase care for the patient with ESKD Integrate the resources available for decision-making support in patients with ESKD in the practice setting 3
4 What is CKD? Chronic kidney disease is defined as: Glomerular Filtration Rate (GFR) < 60 ml/min/1.73m 2 for 3 months with or without evidence of kidney damage. OR Evidence of kidney damage (with or without decreased GFR) for 3 months: albuminuria haematuria after exclusion of urological causes pathological abnormalities anatomical abnormalities. Chronic Kidney Disease (CKD) Management in General Practice, 2 nd edition. Kidney Health Australia: Melbourne,
5 CKD is a major public health problem 1 in 10 Australian adults has CKD Less than 10% of people with CKD are aware they have the condition You can lose up to 90% of your kidney function before experiencing any symptoms Major independent risk factor for cardiovascular disease Common, harmful & treatable 5 Australian Health Survey, 2013 Chronic Kidney Disease (CKD) Management in General Practice, 2 nd edition. Kidney Health Australia: Melbourne, 2012
6 Kidney disease in Australia Australians aged 18 years 21,000 Dialysis or transplant Less than 10% of these people are aware they have CKD 54, ,000 Stage 4-5 CKD Stage 3 CKD 1,146,000 Stage 1-2 CKD 5+ MILLION AT RISK Hypertension / Diabetes 6 Australian Health Survey 2013; ABS population estimates June 2013; ANZDATA 2012 Report CKD staging is according to the CKD-EPI equation
7 CKD survival 5 year survival of patients aged 60 years with common cancers compared with CKD % of 5 Year Survival Testicular Breast Bladder Kidney Transplant Rectal Cervical Colon Stage 5 CKD on dialysis Diagnosis Ovarian 7 Nat. Rev Nephrol 2011; 7:
8 Age and kidneys Relationship between age and kidney function 140 Relationship of egfr to age egfr (ml/min/1.73m 2 ) % Median 97.50% Age (years) Australasian Creatinine Consensus group. MJA 2007; 187(8):
9 Relationship between age and treatment for ESKD Number of dialysed and undialysed cases, by age group at kidney failure onset, No dialysis or transplant Dialysis or transplant 9 Sparke et al, Am J Kidney Dis, 2012
10 Who cares for ESKD patients? For elderly individuals with ESKD who cares for them? General practitioner Geriatrician Nephrologist In practice only a small percentage will be referred to a nephrologist 10
11 Case Study - Jim Background 74 years old Retired farmer Lives at home in a small rural town with his wife of 26 years 11
12 Case study - Jim Medical History Type 2 diabetes Hypertension Hypercholesterolaemia Ischaemic heart disease L Nephrectomy Medications egfr Albumin creatinine ratio Pulmonary fibrosis Insulin-dependent 5 years Neuropathy, retinopathy, previous osteomyelitis & foot ulcers 15 years 15 years 10 years In 2006 for renal cancer Diltiazem, perindopril, aspirin, simvastatin, atenolol 18 ml/min/1.73 m 2 (20 ml/min/1.73m 2 4 months ago) 28 mg/mmol Needs oxygen at night 12
13 Case study - Jim Jim has Stage 4 CKD with macroalbuminuria GFR Stage GFR (ml/min/1.73m 2 ) Normal (urine ACR mg/mmol) Male: < 2.5 Female: < Not CKD unless haematuria, structural a b or pathological abnormalities present Albuminuria Stage Microalbuminuria (urine ACR mg/mmol) Male: Female: Macroalbuminuria (urine ACR mg/mmol) Male: > 25 Female: > Jim s results fit here 5 <15 or on dialysis Chronic Kidney Disease (CKD) Management in General Practice, 2 nd edition. Kidney Health Australia: Melbourne,
14 Case study - Question Q1. At this stage in Jim s CKD what are your main management goals? Options: a) Discuss treatment options for end stage kidney disease b) No need for ongoing management c) Refer to Nephrologist 14
15 Resources Clinical Practice Guidelines for Health Professionals Patients and their families or carers should receive sufficient information and education regarding the nature of ESKD, and the options for the treatment to allow them to make an informed decision about the management of their ESKD CARI guidelines 2010 Acceptance onto Dialysis The cardinal factor for acceptance onto dialysis or continuation of dialysis is whether dialysis is likely to be of benefit. A useful starting point for recommending dialysis is an expectation of survival with a quality of life acceptable to the patient. CARI guidelines 2010 Ethical Considerations 15 Available at
16 Resources Decision Aid for patients Available at /my-decision/ 16
17 Resources Clinical Practice Guidelines for Health Professionals Renal Physicians Association, American Society of Nephrology Guidelines 2010 Available at Stage-Renal-Disease Importance of joint decision using a systematic approach to communicate about diagnosis, prognosis, treatment options, and goals or care for patients with ESKD Includes tools to assess for depression, cognitive impairment, and decision-making capacity 17
18 Case study - Answer a) It s important to discuss the future and ALL the options in full with patients and their family members 3-6 months BEFORE treatment is required and/or urgent. c) Referral to a Nephrologist is recommended when egfr < 30 ml/min/1.73m 2. Appropriate referral not only allows for appropriate management but provides time to discuss treatment options. 18
19 Effective decision making People need time to evaluate what is important to them, their family and their health. 19
20 Treatment options for ESKD Dialysis Haemodialysis involves connecting to a haemodialysis machine either at home or hospital, at least 3 times a week for around 5 hours at a time to cleanse the blood. Peritoneal Dialysis involves a tube being permanently inserted into the abdomen. Special fluids are then introduced regularly to draw waste from the body. 20
21 Treatment options for ESKD Transplantation Kidney transplants come from living or deceased donors. Living donors can be relatives as well as partners and close friends. Waits of 4-7 years for a deceased donor organ are not uncommon. A transplant from a living donor can be performed before dialysis is started (pre-emptive transplantation). Pre-emptive transplants make up 11% of all transplant operations in Australia. 21
22 Treatment options for ESKD Non-dialysis care Some people decide not to have dialysis or a kidney transplant, and instead choose a non-dialysis treatment, also known as supportive or conservative care. This choice lets kidney failure run its natural course and focuses on treating symptoms. Non-dialysis treatment aims to preserve kidney function for as long as possible through dietary management and medications, but cannot stop the decline in kidney function. 22 Further information on treatment options available at or by calling Kidney Health Information Service on
23 Dialysis Transplant Non-Dialysis Treatment Treatment done at home or in a dialysis centre using a machine or special dialysis fluid. An operation to insert a transplanted kidney. Continue to see a kidney specialist to manage symptoms, diet & medication. Suitability Most people with ESKD are suitable, unless they have serious illnesses affecting other body systems. Typically suited to younger patients without serious health issues besides kidney disease. Suitable for all patients - usually chosen if dialysis would result in poor quality of life or life expectancy. Life and work Home dialysis are more flexible than others. Resume normal activities 3 6 months after transplant Health will deteriorate, life expectancy will decrease Diet and fluids Some restrictions - depends on type of dialysis. No restrictions, but it is important to eat healthily. Medications may increase appetite. Some restrictions. Travel and holidays Can travel more easily with some types of dialysis. Others need planning, and travel may not always be possible. Travel possible - need to discuss safety and provision of ongoing treatment with doctor. Travel possible - need to discuss safety and provision of ongoing treatment with doctor Health Health and wellbeing is less than that of people with normal kidney function or a transplant, but better than before starting dialysis. Medications needed to help the body accept the new kidney. Transplant operations can have complications. Manage symptoms through diet and medication. Life expectancy will be decreased. 23
24 CKD pathway Primary Care CKD Management Nephrology Unit CKD Management Palliative Care Screen patients for CKD risk factors CKD diagnosis / progression Referral to Nephrologist CKD risk factor reduction, CKD management CKD 3/4 Diagnosis & treatment, treat comorbidities & slow progression CKD progression CKD 3/4 Estimate progression, treat complications, educate patient & family about all treatment options CKD 5 Dialysis, transplantation, or non-dialysis care Palliative care Manage complications of CKD 24
25 Decision making It is not a static process and is not limited to a single point in time Peritoneal dialysis Home dialysis Transplant Non dialysis Nocturnal dialysis Haemodialysis 25
26 Case study - Question Imagine that you have recently learned that you have stage 4 CKD and are likely to progress to ESKD within the next 3 months. Use the My Choice Decision Aid to consider the pros and cons for each of the management options (dialysis, transplant, nondialysis). Q2. What factors in your own situation might change your management choice? 26
27 27
28 Treatment options what is important for patients? Lifestyle and QOL issues are very important for patients: - Time of day dialysis is available - Number of visits to hospital/centre for dialysis per week - Difficulty and cost of transport to dialysis - Travel and holiday options Patients approaching ESKD may be willing to trade considerable life expectancy to reduce the burden and restrictions imposed by dialysis 28 Morton RL et al. CMAJ 2012
29 Case study - Jim You discuss each treatment option with Jim and his wife. You feel that Jim has a good understanding of the options available. Q3. Discuss what you could do if Jim was struggling with the decision about treatment. 29
30 Case study - Question Jim makes an appointment to see you without his wife present. He makes it clear that he does not want to be hooked up to machines; he wants to be at home. He has told his wife and children, but they are not happy with this decision. Q4. Where do things stand legally when a patient refuses dialysis treatment, or chooses to stop dialysis treatment? 30
31 Legal issues concerns about withholding and withdrawal of dialysis Unless clearly incompetent, patients have an absolute legal and moral right to consent to, withdraw from or refuse any treatment (including dialysis) without having any obligation to explain their decision. Doctors have a responsibility to: ensure that the patient's decision is fully informed seek to engage the patient in a discussion of their options and reasons continue to support the patient in whatever choices the patient makes If a doctor has concerns about the patient' s competence, or about the legal implications for the doctor of the patient's decision, then they should: seek another opinion discuss with colleagues in the practice (& the patient's nephrologist if they have one), and/or obtain advice from their medical indemnity provider 31
32 Case study - Question Q5. How can you help Jim s family understand Jim s decision for non-dialysis care? 32
33 Survival Dialysis versus a non-dialysis pathway An Australasian study showed that elderly ESKD patients who commence dialysis have considerable mortality. 1-year survival of 77%, 2-year survival of 59% and 3year survival of 45% Survival of elderly ESKD patients on a non-dialysis pathway is difficult to estimate because of lack of data. Survival without dialysis may be between 9-22 months. 33 Foote C, Ninomiya T, Gallagher M et al. NDT 2012
34 Survival and dialysis Survival of patients aged 75 and 85 years initiating dialysis in Australasia ( ) compared with survival of 75- and 80-yearolds from the general Australian population 34 Australia s Health Cat. no. AUS 99. Canberra: AIHW, [Cited 10 Feb 2011] Rosemary Masterson and Celine Foote. Perspectives The Issue Surrounding End-Stage Kidney Disease and Dialysis in the Elderly and Those with Co-morbidities. ANZSN Renal Supportive Care Guidelines Nephrology 18 (2013)
35 Survival information for patients 18 year observational study 844 patients 696 RRT 155 non-dialysis conservative care Survival less in nondialysis than in RRT (21.2 vs 67.1 months, p<0.001) But, there are other issues to consider Chandna SM. et al. NDT 2010
36 Survival is related to age 36 Chandna SM. et al. NDT 2010
37 Survival is related to co-morbidities 37 Chandna SM. et al. NDT 2010
38 Quality of life and survival Single-centre prospective study; 170 patients with progressive stage 4 or 5 CKD Minimum 30 months follow-up Dialysed patients survived 13 months longer (after controlling for comorbidity, Karnofsky Performance Scale score, age, SF-36, and propensity) Most of the increase is absorbed by dialysis days Quality of life measures did not improve after dialysis initiation Haemodialysis 1200 Life satisfaction decreased with dialysis Conservative care 1000 Days Quality of life remained stable with conservative care Survival Time 38 Survival Time minus dialysis days Da Silva-Gane et al, Clin J Am Soc Nephrol, 2012
39 Case study - Jim Jim and his family visit the local dialysis centre and meet with the renal team and community palliative care team. After a series of conferences Jim and his family agree the best pathway is for Jim to have supportive care at home, with involvement of the local GP and palliative care team What to expect now 39
40 Non-dialysis pathway Palliative Care Nephrology Unit CKD Management Primary Care CKD Management Screen patients for CKD risk factors CKD 3/4 Diagnosis & treatment, treat comorbidities & slow progression CKD diagnosis / progression CKD progression Referral to Nephrologist CKD risk factor reduction, CKD Management CKD 3/4 Estimate progression, treat complications, educate patient and family about all options: prepare for conservative care Palliative Care Manage complications of CKD 40 CKD 5 Treat complications, symptom burden, transition to PC
41 Trajectory of illness of advanced CKD Still trying to treat the underlying disease Functional decline months to years Episodes of acute (serious) reversible complications Level of Function High Low 41 Time Death Swidler, ASN curriculum
42 Case study - Jim Jim is seen a few months later and is complaining of the following issues Surges of neuropathic pain in his feet Ongoing breathlessness and nausea Severe itch Difficulty sleeping and more recently A sensation of being unable to keep his legs still Q6. Jim s family believe that Jim would not be experiencing these symptoms if he was on dialysis. a) True b) False 42
43 False... Symptoms in ESKD managed with and without dialysis Dialysis Non-dialysis Fatigue/tiredness 71% 75% Pruritus 55% 74% Constipation 53% Anorexia 49% 47% Pain 47% 53% Sleep disturbance 44% 42% Anxiety 38% Dyspnoea 35% Nausea 33% Restless legs 30% 48% Depression 27% 40% 43 61% Murtagh F et al, J Pall Med 2007; Adv Chr Kidney Dis 2007
44 Symptom assessment Several symptom inventory tools validated for ESKD Allow patients and clinicians to focus on symptoms causing most difficulty Simple example is the Palliative care Outcome Scale Symptoms (POS-S) Renal instrument - Validated for renal patients - Symptom scores nil overwhelming
45 Symptom management 45 Control of pain Control of symptoms related to anaemia Treatment of pruritus Treatment of nausea Treatment of fluid retention Psychosocial End of life care
46 46
47 Case study - Jim You see Jim for his six-monthly review. His egfr has decreased to 10 ml/min/1.73m2 (previously 18 ml/min/1.73m2) Jim has Stage 5 CKD with macroalbuminuria Albuminuria Stage 47 GFR GFR Stage (ml/min/1.73m2) a b <15 or on dialysis Normal (urine ACR mg/mmol) Male: < 2.5 Female: < 3.5 Microalbuminuria Macroalbuminuria (urine ACR (urine ACR mg/mmol) mg/mmol) Male: Male: > 25 Female: Female: > 35 Not CKD unless haematuria, structural or pathological abnormalities present Jim s results fit here Chronic Kidney Disease (CKD) Management in General Practice, 2nd edition. Kidney Health Australia: Melbourne, 2012
48 Case study - Jim The rate at which his kidney function has declined allows a rough prediction kidney function is likely not to survive longer than a year. 30 Predicted decline of GFR
49 Case study - Question Using the POS-S Renal tool you identify that Jim is having the most difficulty with pain control. Q7. What are the recommended steps for managing pain for patients undergoing non-dialysis treatment for ESKD? 49
50 Pain in ESKD Common in ESKD with and without dialysis Variety of etiologies - Musculoskeletal - Neuropathic (diabetic neuropathy) - Ischaemic (causes nociceptive, visceral, and neuropathic pains) Multidisciplinary approach consisting of nephrology, pain medicine, palliative care, general practice, nursing and other relevant disciplines is advised 50
51 Pain management 1. Important to try to determine a cause for the pain 2. Mild or moderate pain - paracetamol or tramadol Analgesics not as effective for neuropathic pain Avoid NSAIDS and COX-2 inhibitors - can adversely affect kidney function 3. Moderate to severe pain Kidney failure has implications for opioid choice - many are renally excreted Opioid choice and dose/interval individualised to each patient - Hydromorphone use is controversial as its metabolite can accumulate but evidence in humans in lacking - Fentanyl safest as its renally excreted metabolites are inactive - Morphine and oxycodone have active metabolites which accumulate and can be toxic 51
52 Alternatives for severe neuropathic pain Buprenorphine (Norspan) patches Fentanyl (Durogesic) patch Ketamine * Methadone* * Best used under the supervision of the Pain or Palliative Care teams More information on the use of drugs in patients with kidney impairment can be found in The Renal Drug Reference Guide 52
53 Anaemia Symptoms are common in ESKD Prevalence increases as kidney function worsens Can contribute to symptoms of fatigue, depression and sleep disturbances Management: - Other causes of anaemia should be considered and excluded PBS criteria EPO only reimbursed after Hb <100g/L Need to have Nephrologist endorsement to start Ensure not iron deficient All respond need to dose titrate Most self administer SC every 1, 2 or 4wks (depending on EPO formulation) - All will need extra iron (oral or i.v.) 53
54 Pruritus Common in ESKD with and without dialysis Various etiologies suggested: 54 inadequate dialysis secondary hyperparathyroidism dry skin divalent ion accumulation and precipitation in skin mast cell dysregulation abnormal cutaneous innervation aluminum toxicity elevated serum histamine elevated serum serotonin substance P altered immune function
55 Pruritus management Exclude potential other causes (e.g. allergies, scabies) Pharmacological management - Gabapentin 100mg after dialysis (not PBS approved) - If on supportive pathway (egfr<15) then start 100mg every 2nd night - Evening primrose oil (1 capsule bd) - Thalidomide (100mg nocte) - UV B Therapy Skin moisturisers advised - Capsaicin cream (although patients may not tolerate the initial burning sensation) 55
56 Restless legs syndrome Common in ESKD with and without dialysis May increase in severity as death approaches Affects quality of life through sleep disturbance Home therapies such as massage, warm baths, warm/cool compresses, relaxation techniques may be beneficial 56
57 Restless legs syndrome Pharmacological management - Iron replacement therapy - Gabapentin 100mg after dialysis* - If on supportive pathway (egfr<15) then start 100mg every 2nd night - Dopaminergic agents or dopamine agonists (e.g. levodopa, Ropinirole) - Benzodiazepines If the patient is troubled by both uraemic pruritus and restless legs syndrome commence Gabapentin as it has been shown to have efficacy in both symptoms. It is also efficacious for painful diabetic peripheral neuropathy. *Gabapentin is PBS indicated for refractory neuropathic pain 57
58 Dyspnoea Approaches 80% in final days Effectively controlled in < 50% in cases Multifactorial may include cardiac disease, respiratory disease, fluid overload, anaemia Pneumonia is a common final event Treatment requires urgency: - often rapid progression - severe distress - often only hours before dying 58
59 Management of dyspnoea Nonpharmacological Pharmacological Pharmacological detail Calm reassurance Oxygen Fan Sedatives Conscious (lorazepam 0.5mg SL bd) Unconscious (midazolam) Sitting upright Opioids Commence with small doses of hydromorphone mg qid and carefully titrate to response Open window Antisecretory agents Scopolamine, glycopyrrolate 59
60 Nausea Common and often multifactorial in origin Significantly affects quality of life and nutritional intake Metoclopramide hydrochloride as first line Haloperidol recommended (start with dose at lower end of effective range e.g. 0.5mg bd) Levomepromazine can be used if symptoms persist, but it is more sedating Cyclizine not recommended as may cause hypotension or arrhythmia in patients with cardiac comorbidities; use only under palliative specialist supervision 60
61 Case study - Jim For Jim the following treatment and dosing was considered on his non dialysis pathway Gabapentin for neuropathic pain, pruritus and restless leg syndrome (may also help with sleep?) Titrate up by 100mg increments according to tolerability and response - If egfr >50 commence 100mg tds - If egfr commence 100mg nocte 100mg bd and titrate up - If egfr commence 100mg nocte and titrate - If egfr < 15 commence 100mg every second night and titrate up 61
62 Case study - Jim For Jim s nausea Metoclopramide HCl 10mg half hour before meals - Also helps early satiety and gastroparesis related to diabetes Haloperidol was used - Elimination is via bile, faeces and urine; If egfr < 10 or dialysis begin with low end of dose range; In elderly use low doses to avoid extrapyramidal reactions; Increased risk of sedation in renal failure and 50% of normal dose is recommended - Minimal commencing dose mg. - Typical commencing doses for: * Nausea mg bd 62 * Delirium - 1mg bd Ondansetron not recommended due to it being expensive and constipating.
63 Case study - Jim For Jim s breathlessness and possibly sleep Lorazepam was used - Elimination is renal (88%) and faecal (7%) - If egfr <10ml/min/1.73m2 or dialysis begin with low end of dose range and titrate according to response - CNS adverse effects more pronounced in patients with renal impairment - Minimal commencing dose mg-1mg bd (sublingual or oral) - Alternatives small dose of hydromorphone mg qid Note: For terminal secretions Glycopyrrolate 0.4mg-0.8mg SL Q 1-2 hourly What other management issues may arise? 63
64 Fluid retention Pathway of correct hydration often narrow Easily get too dry Easily get too wet Essential to avoid pulmonary oedema Utilise Heart failure regimen Daily weight Fixed sensible fluid volume input Vary frusemide dosage to maintain stable weight Ideal weight is when there is mild ankle oedema at end of day Accept that the ideal weight may be one where GFR is somewhat compromised 64
65 Psychosocial issues Depression and/or anxiety is common throughout CKD and can affect up to 40% of conservatively managed patients May be difficult to formally assess as physical symptoms of ESKD are identical to diagnostic criteria When in doubt, seek a psychiatry review Several SSRIs are safe to use without dose adjustment (e.g. Citalopram, Fluoxetine, Sertraline) For panic attacks consider Benzodiazepines 65
66 Terminal phase care: how to ensure comfort Communication Anticipating symptoms, proactive response - Pain (generally only if a pre-existing problem) Nausea Restlessness, confusion Dyspnoea fluid balance, pneumonia Pruritus Myoclonus, twitching Communication Anticipating need for non-oral medication routes Communication 66
67 Delirium in terminal phase care Common: 80 90% in last few weeks Almost always multifactorial; illness, medications May rapidly worsen, with paranoia and agitation Very distressing for all involved Not likely to be reversible in last few days of life, such as after withdrawing from dialysis (this is d/t uraemic encephalopathy) Main intervention is effective sedation If conscious haloperidol 1mg bd sci and 1-2mg prn If unconscious - midazolam Subcutaneous route 2.5 mg - 5 mg q 4 hours ; about 1/3 as potent as IV route but IV is complicated and impractical in reality 67
68 Communication in terminal phase care: issues regarding sedation for delirium Delirium not reversible; ongoing physiologic decline Once effectively sedated, will not likely awaken again Medications not hastening process, but ensuring comfort Encourage ongoing communication by family, including private time alone with patient Be cautious in presenting non-choices as choices there are no other realistic options but aggressive sedation in trying to settle a restless, agitated, delirious person who is imminently dying 68
69 Case study - Question Q8. How have your thoughts on ESKD treatment decision-making changed as a result of this workshop? 69
70 Dying with Dignity What Patients Want? Meanings of dying with dignity from perspective of patients, families and Health Professionals (HPs) 70 Guo & Jacelon Palliative Medicine 2014
71 Recommendations It is both advisable and appropriate to initiate ACP with an ESRD patient 1. Initiation ideally by the Nephrologist with other team members e.g. social worker, dialysis nurse Where possible, ACP discussions should include the patient s family. The content of the discussion and any documentation should include: Information on the nature of ESRD, prognosis and quality of life. Selecting a substitute decision maker Exploring expectations, goals of care and values An indication as to what circumstances the patient would wish that dialysis and all other active treatment cease and a purely palliative approach commence. This process may continue over many conversations ACP discussions should be documented and universally available to relevant parties.
72 Advanced Care Planning Advance Care Planning should be initiated in i. all competent patients aged 65 years and above, and ii. all competent patients, irrespective of age, who fulfil one or more of the following criteria : The Nephrologist would not be surprised if the patient were to die in the next 12 months. Two or more significant co-morbidities Poor functional status Chronic malnutrition. Poor quality of life 72
73 Key points Treatment decision making process is ongoing Need to respect individual informed decisions Tools are available to help decision-making process Well managed non-dialysis pathway an attractive option particularly when co-morbidities present GPs play an important role in symptom management Communication critical to ensuring comfort in terminal phase 73
74 Resources CKD Management in General Practice 2012 Guidelines booklet Available at 74
75 Resources RACGP Advanced Care Planning Available at 75
76 Resources Kidney Health Information Service Free call information service for people living with / affected by kidney disease 76
77 Resources CKD patient fact sheets Available along with more kidney health fact sheets at > For Patients > Health Fact Sheets 77
78 Join the Kidney Community KIDNEY COMMUNITY members receive a monthly newsletter from KHA allowing you to access: Information and invitations to KHA's education and support activities Updates on medical research in kidney disease Updates on clinical trials and research opportunities Information on advocacy opportunities and government relations issues Information on community and corporate events held by Kidney Health Australia To join the kidney community, community@kidney.org.au 78
79 Thankyou for participating in this workshop Please complete your evaluation form before leaving. 79
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,
More informationModels of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK
Models of Chronic Kidney Disease Care and Initiation of Dialysis Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Early Crash Landings Talk Outline Pathways & Definitions Guideline recommendations
More informationThe Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool
The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline
More informationCollaborative Care Plan for PAIN
1. Pain Assessment *Patient s own description of pain is the most reliable indicator for pain assessment. Pain intensity to be assessed using the ESAS (Edmonton Symptom Assessment Scale) Use 5 th Vital
More informationReview of Pharmacological Pain Management
Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization
More informationMAKING CHOICES: Living with advanced kidney disease
MAKING CHOICES: Living with advanced kidney disease A guide to Maximum Conservative Care for those considering alternatives to dialysis Is dialysis the right choice for me? For many patients with renal
More informationService delivery interventions
Service delivery interventions S A S H A S H E P P E R D D E P A R T M E N T O F P U B L I C H E A L T H, U N I V E R S I T Y O F O X F O R D CO- C O O R D I N A T I N G E D I T O R C O C H R A N E E P
More informationRenal Disease in Type 2 Diabetes Mellitus
Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman
More informationDiabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
More informationOUTLINE Supportive care management of the advanced CKD patient
RENAL SUPPORTIVE CARE. NURSING EXPERIENCE AND PERSPECTIVES Renal Supportive Care Symposium 2013 Elizabeth Josland CNC OUTLINE Supportive care management of the advanced CKD patient Recognise patients who
More informationUse of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal
Use of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal Great care is required when prescribing opioids to patients with impaired renal function. Many
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: Frenchay 0117 340 6692 Southmead 0117 323
More informationPROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain
P a g e 1 PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain Clinical Phase 4 Study Centers Study Period 25 U.S. sites identified and reviewed by the Steering Committee and Contract
More informationWhat are the current rates of Dialysis Modalities? 2. What are the findings of the Consumer Perspectives Survey? 3
Contents A decision aid for the treatment of kidney disease A Guide for Health Professionals about this tool My Kidneys Contents Background 2 What are the current rates of Dialysis Modalities? 2 What are
More informationInDependent Diabetes Trust
InDependent Diabetes Trust Kidneys and Diabetes Updated July 2015 Registered Company Number 3148360 Registered Charity No 1058284 Contents Introduction Healthy Kidneys Kidney disease and diabetes The use
More informationGuideline for Microalbuminuria Screening
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
More informationOpioid toxicity and alternative opioids. Palliative care fixed resource session
Opioid toxicity and alternative opioids Palliative care fixed resource session Opioid toxicity and alternative opioids - aims Know the symptoms of opioid toxicity Understand which patients are at higher
More informationGuidance on competencies for management of Cancer Pain in adults
Guidance on competencies for management of Cancer Pain in adults Endorsed by: Contents Introduction A: Core competencies for practitioners in Pain Medicine B: Competencies for practitioners in Pain Medicine
More informationMANAGING ANEMIA. When You Have Kidney Disease or Kidney Failure. www.kidney.org
MANAGING ANEMIA When You Have Kidney Disease or Kidney Failure www.kidney.org About the Information in this Booklet Did you know that the National Kidney Foundation (NKF) offers guidelines and commentaries
More informationIs a kidney transplant right for me?
Is a kidney transplant right for me? Your guide to the transplant process www.esrdncc.org Contents Introduction 3 What is a Transplant Center? 4 What is the Waiting List? 5 What Happens After the Surgery?
More informationGFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working
GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National
More informationDiabetic Nephropathy
Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal
More informationIdentifying and treating long-term kidney problems (chronic kidney disease)
Understanding NICE guidance Information for people who use NHS services Identifying and treating long-term kidney problems (chronic kidney disease) NICE clinical guidelines advise the NHS on caring for
More informationAdjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.
Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,
More informationManaging Anemia When You Are on Dialysis. Stage 5
Managing Anemia When You Are on Dialysis Stage 5 What is anemia? Anemia happens when your red blood cells are in short supply. Red blood cells carry oxygen from your lungs to all parts of your body, giving
More informationPolicy for the issue of permits to prescribe Schedule 8 poisons
Policy for the issue of permits to prescribe Schedule 8 poisons May 2011 Introduction The Victorian Drugs, Poisons and Controlled Substances (DPCS) legislation sets out certain circumstances when a medical
More informationChronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1
Chronic Kidney Disease (CKD) Algorithm Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm (See NICE Clinical Guideline CG73 1 and Quality Standards 2 ) Who should have
More informationHYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
More informationChronic Kidney Disease
Page 1 of 6 Chronic Kidney Disease Chronic kidney disease (CKD) means that your kidneys are not working as well as they once did. Various conditions can cause CKD. Severity can vary but most cases are:
More informationMANAGEMENT OF CHRONIC NON MALIGNANT PAIN
MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges
More informationPOST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics
POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped
More informationChronic Kidney Disease and Diabetes
Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by
More informationHigh Blood Pressure and Kidney Disease
High Blood Pressure and Kidney Disease National Kidney and Urologic Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH The kidneys play a key
More information2.6.4 Medication for withdrawal syndrome
.6.3 Self-medication Self-medication presents a risk during alcohol withdrawal, particularly when there is minimal supervision (low level and medium level 1 settings). Inform patients of the risk of selfmedication
More informationKidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE
Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.
More informationThe Last Hours of Living
The Last Hours of Living Ian Anderson Continuing Education Program in End-of of-life Care The Last Hours of Living! Over 90% of us will die after long illness! Last hours can be some of most significant
More informationEND OF LIFE MEDICINES INFORMATION PACK
END OF LIFE MEDICINES INFORMATION PACK Advice on end of life medication is available from the nursing and medical team at St Nicholas Hospice Care - telephone 01284 766133. Many drugs used in palliative
More informationIatrogenesis. Suzanne Beyea,, RN, PhD, FAAN Associate Director: Centers for Health and Aging
Iatrogenesis Suzanne Beyea,, RN, PhD, FAAN Associate Director: Centers for Health and Aging Iatrogenesis Definition from the Greek word, iatros,, meaning healer, iatrogenesis means brought forth by a healer
More informationDiabetes and the Kidneys
Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease
More informationPain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010
Pain Control Aims General principles of pain control Basic pharmacokinetics Case history demo Opioids renal failure John Welsh 8/4/2010 Pain Control Morphine is gold standard treatment for moderate to
More informationGUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE
GUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE Dr Millicent Chikoore MBBS MRCPsych Dr O Lagundoye MBBS MRCPsych Community based alcohol detoxification is a safe and effective option for
More informationChronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD
Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in
More informationAcute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC
Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635
More informationAntipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers
SUPPLEMENT 1: (Supplementary Material for online publication) Antipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers About this
More informationHospice and Palliative Medicine
Hospice and Palliative Medicine Maintenance of Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills
More informationPain Management in Palliative and Hospice Care
Pain Management in Palliative and Hospice Care Donna Butler, MSN, ANP-BC, OCN, ACHPN, FAAPM Current Status of Pain Cancer patients at EOL- 54% have pain AIDS with prognosis < 6mons- intense pain Less research
More informationPOAC CLINICAL GUIDELINE
POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal
More informationPalliative Care in Patients with End-Stage Renal Disease. Stephanie Flecksteiner, MD PGY-3 January 15, 2014
Palliative Care in Patients with End-Stage Renal Disease Stephanie Flecksteiner, MD PGY-3 January 15, 2014 Outline Epidemiology of ESRD Current limitations of palliative care in ESRD Prognosis in ESRD
More informationGuidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling
Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate
More informationSystolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
More informationEmergency Room Treatment of Psychosis
OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different
More informationRheumatoid Arthritis. GP workshop 15 January 2011
Rheumatoid Arthritis GP workshop 15 January 2011 Case 1 A 72 year old Malay woman with RA comes for routine follow up. She feels generally unwell in the last 5 days. Appetite is fair. Her joints are fine.
More informationSUMMARY OF RECOMMENDATIONS
SUMMARY OF RECOMMENDATIONS FOR THE LONG- TERM TREATMENT OF RLS/WED from AN IRLSSG TASK FORCE Members of the Task Force Diego Garcia- Borreguero, MD, Madrid, Spain* Richard Allen, PhD, Baltimore, MD, USA*
More informationManaging Chronic Pain in Adults with Substance Use Disorders
Question from chapter 1 Managing Chronic Pain in Adults with Substance Use Disorders 1) What is the percent of chronic pain patients who may have addictive disorders? a) 12% b) 22% c) 32% d) 42% 2) Which
More informationNew York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification
More informationStrengthening of palliative care as a component of integrated treatment throughout the life course
EXECUTIVE BOARD EB134/28 134th session 20 December 2013 Provisional agenda item 9.4 Strengthening of palliative care as a component of integrated treatment throughout the life course Report by the Secretariat
More informationThese guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes.
This is a new guideline. These guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes. It incorporates NICE clinical
More informationHow To Treat An Elderly Patient
1. Introduction/ Getting to know our Seniors a. Identify common concepts and key terms used when discussing geriatrics b. Distinguish between different venues of senior residence c. Advocate the necessity
More informationConjoint Professor Brian Draper
Chronic Serious Mental Illness and Dementia Optimising Quality Care Psychiatry Conjoint Professor Brian Draper Academic Dept. for Old Age Psychiatry, Prince of Wales Hospital, Randwick Cognitive Course
More informationAsthma, anxiety & depression
Anxiety and are common in people with asthma. The good news is that there are effective treatments both for asthma and for anxiety and. With careful management, the symptoms of anxiety and can be treated
More informationDepression is a common biological brain disorder and occurs in 7-12% of all individuals over
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),
More informationMedical Coverage Policy Monitored Anesthesia Care (MAC)
Medical Coverage Policy Monitored Anesthesia Care (MAC) Device/Equipment Drug Medical Surgery Test Other Effective Date: 9/1/2004 Policy Last Updated: 1/8/2013 Prospective review is recommended/required.
More informationProtocol for the safe administration of iodinated contrast media in diagnostic radiology
Protocol for the safe administration of iodinated contrast media in diagnostic radiology Protocol statement: This protocol applies to all staff within Radiology Departments at Heart of England NHS Foundation
More informationElizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller
Elizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller School of Medicine/University of Miami Question 1 You
More informationMEDICATION ABUSE IN OLDER ADULTS
MEDICATION ABUSE IN OLDER ADULTS Clifford Milo Singer, MD Adjunct Professor, University of Maine, Orono ME Chief, Division of Geriatric Mental Health and Neuropsychiatry The Acadia Hospital and Eastern
More informationCalculating the stage of Renal Disease
Calculating the stage of Renal Disease When the Refresh Template/Check Labs button is depressed, the box next to MDRD, will be automatically checked. In order to use this in the calculation of the stage
More informationPrimary Care management of Overactive Bladder (OAB)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Primary Care management of Overactive Bladder (OAB) Prescribing Tips All medicines for OAB have similar dose-related efficacy. More than one agent (up
More informationDepression Flow Chart
Depression Flow Chart SCREEN FOR DEPRESSION ANNUALLY Assess for depression annually with the PHQ-9. Maintain a high index of suspicion in high risk older adults. Consider suicide risk and contributing
More informationPatients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by
Dementia is the permanent loss of multiple intellectual functions resulting from neuronal death. Dementia afflicts 10% of individuals over the age of 65 and these patients survive approximately seven years
More informationConservative Kidney Management
Conservative Kidney Management Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationPHSW Procedural Sedation Post-Test Answer Key. For the following questions, circle the letter of the correct answer(s) or the word true or false.
PHSW Procedural Sedation Post-Test Answer Key 1 1. Define Procedural (Conscious) Sedation: A medically controlled state of depressed consciousness where the patient retains the ability to continuously
More informationHow does a kidney transplant differ from dialysis?
TA L K I N G A B O U T T R A N S P L A N TAT I O N Frequently Asked Questions about Kidney Transplant Evaluation and Listing If your kidneys have stopped working properly, or may stop working soon, you
More informationDiabetes at the End of Life. Dr David Kerr MD Bournemouth Diabetes and Endocrine Centre www.b-dec.co.uk
Diabetes at the End of Life Dr David Kerr MD Bournemouth Diabetes and Endocrine Centre www.b-dec.co.uk A good way to live longer is to move to the eastern part of the English county of Dorset and take
More informationUNIT VIII NARCOTIC ANALGESIA
UNIT VIII NARCOTIC ANALGESIA Objective Review the definitions of Analgesic, Narcotic and Antagonistic. List characteristics of Opioid analgesics in terms of mechanism of action, indications for use and
More informationJames F. Kravec, M.D., F.A.C.P
James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice
More informationMOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines
MOH CLINICL PRCTICE GUIELINES 2/2008 Prescribing of Benzodiazepines College of Family Physicians, Singapore cademy of Medicine, Singapore Executive summary of recommendations etails of recommendations
More informationUnderstanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
More informationDepression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
More informationCOMPREHENSIVE MANAGEMENT OF THE ELDERLY PATIENT WITH MANIA
COMPREHENSIVE MANAGEMENT OF THE ELDERLY PATIENT WITH MANIA Manic depressive illness is a biological brain disorder that produces significant alterations of mood and psychosis. Mania in the elderly occurs
More informationManaging depression after stroke. Presented by Maree Hackett
Managing depression after stroke Presented by Maree Hackett After stroke Physical changes We can see these Depression Emotionalism Anxiety Confusion Communication problems What is depression? Category
More informationIs a Kidney Transplant Right for Me?
Is a Kidney Transplant Right for Me? Network 8 Introduction What do singer Natalie Cole, actor Ken Howard, funny men Tracy Morgan and George Lopez and fashion reporter Steven Cojocaru have in common? They
More informationType 2 Diabetes workshop notes
Group 1 notes Abi / Nicole Type 2 Diabetes workshop notes 4.1 Population The group discussed the following sub groups that may need addressing: Men-as they tend to die earlier compared with women, their
More informationPPS UNDERWRITING GUIDE FOR APPLICANTS
PPS UNDERWRITING GUIDE FOR APPLICANTS UNDERWRITING guide 2013 WHAT HAPPENS WHEN YOU SUBMIT YOUR APPLICATION FOR INSURANCE? Once an application is submitted it is put through a number of processes to ensure
More informationPRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION
Hull & East Riding Prescribing Committee PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION For guidance on Primary Prevention please see NICE guidance http://www.nice.org.uk/guidance/cg181
More informationQUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE
QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney
More informationWITHDRAWAL OF ANALGESIA AND SEDATION
WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses
More informationTECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management
TECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management WHY IS THIS IMPORTANT? Depression causes fluctuations in mood, low self esteem and loss of interest or pleasure in normally
More informationChemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015
Chemobrain Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Terminology Chemotherapy-associated cognitive dysfunction Post-chemotherapy cognitive impairment Cancer treatment-associated cognitive
More informationObjectives. Pain Management Knowing How To Help Yourself. Patients and Family Requirements. Your Rights As A Consumer
Objectives Pain Management Knowing How To Help Yourself Jackie Carter, RN MSN CNS Become familiar with the definitions of pain Be aware of your rights to have your pain treated Become familiar with the
More informationUnderstanding Treatment Options for Renal Therapy
Understanding Treatment Options for Renal Therapy Kidney failure happens to many different people for many different reasons 1 What causes kidney failure? Diabetes Chronic infection High blood pressure
More informationChronic kidney disease hospitalisations in Australia
Chronic kidney disease hospitalisations in Australia 2000 01 to 2007 08 August 2010 Australian Institute of Health and Welfare Canberra Cat. no. PHE 127 The Australian Institute of Health and Welfare is
More informationCHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications
CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)
More informationPain and symptom management in pleural mesothelioma
Pain and symptom management in pleural mesothelioma MARF October 2006 Helen Clayson Hospice of St Mary of Furness University of Sheffield Outline Background to the study Symptoms in mesothelioma What is
More informationAnticipating And Preparing For Predictable Clinical Challenges In The Medical Care Of The Terminally Ill Person Wishing To Die At Home.
Mike Harlos MD, CCFP, FCFP Professor, Faculty of Medicine, University of Manitoba Medical Director, WRHA Palliative Care Sub Program Medical Director, St. Boniface General Hospital Palliative Care Room
More informationNICE Clinical guideline 23
NICE Clinical guideline 23 Depression Management of depression in primary and secondary care Consultation on amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised
More informationPain Medication Taper Regimen Time frame to taper off 30-60 days
Pain Medication Taper Regimen Time frame to taper off 30-60 days Medication to taper Taper Regimen Comments Methadone Taper by no more than 25% Morphine Taper by no more than 25% Tramadol Taper by no more
More informationAbstral Prescriber and Pharmacist Guide
Abstral Prescriber and Pharmacist Guide fentanyl citrate sublingual tablets Introduction The Abstral Prescriber and Pharmacist Guide is designed to support healthcare professionals in the diagnosis of
More informationClient Summary Palliative Care
Client Summary Palliative Care DRAFT 2, March 2014 Gippsland Region Palliative Care Consortium Clinical Practice Group Policy No. Title Keywords Ratified GRPCC Client Summary Palliative Care After-hours,
More informationHealth and Behavior Assessment/Intervention
Health and Behavior Assessment/Intervention Health and behavior assessment procedures are used to identify the psychological, behavioral, emotional, cognitive, and social factors important to the prevention,
More information